Should tamoxifen users be screened for endometrial lesions?

MeSH terms

• Antineoplastic Agents, Hormonal / adverse effects*
• Antineoplastic Agents, Hormonal / therapeutic use
• Breast Neoplasms / drug therapy
• Dose-Response Relationship, Drug
• Endometrial Neoplasms / chemically induced*
• Endometrial Neoplasms / prevention & control*
• Estrogen Antagonists / adverse effects*
• Estrogen Antagonists / therapeutic use
• Female
• Humans
• Mass Screening
• Risk Factors
• Tamoxifen / adverse effects*
• Tamoxifen / therapeutic use
• Time Factors